Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Janssen Research & Development
FDA Inspection
•Janssen Research & Development•June 14, 2024

Janssen Research & Development – FDA Inspection, Jun 14, 2024

Record Details

This FDA Inspection record concerns Janssen Research & Development, with an inspection on June 14, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Janssen Research & Development
Inspection Date
June 14, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Sri Rama Kr Yellela (Issuing Officer)
View Company Profile

ID · 0b6e6ed2-dbb3-4cbf-bb24-b14cb87ea48f

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number
1245603
FDA center
Human Drugs
Project area
Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Janssen Research & Development
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.